Mateescu DM, Gavrilescu DM, Mincioaga RI et al. · Pharmaceutics · PMID 42797253
From the original abstract
“Until these requirements are met and controlled clinical efficacy is demonstrated, GHK-Cu should be regarded as a promising but unproven therapeutic cargo rather than a…”
From the closing sentence of the indexed abstract. This is a shortened quotation; the full sentence continues in the original abstract.
Read the full abstract & conclusionThis paper brings together existing research. Its conclusions depend on the included studies and their methods; it is not a separate treatment trial.
A brief excerpt cannot capture the complete methods, results, adverse events, or limitations. Check the full abstract and original paper before interpreting the finding.
Educational research information. A publication does not verify the identity, quality, or safety of products sold here.
Back to GHK-Cu studies